GLP-1 drugs affect plastic surgery through anesthesia risks (delayed gastric emptying), altered wound healing, body composition changes requiring filler adjustment, and need for preoperative medication management protocols.
New surgical patient populationGLP-1 drugs create unique challenges for plastic surgery: delayed gastric emptying, "Ozempic face" requiring fillers, and body composition changes affecting contouring timing
What the researchers found
GLP-1 considerations for plastic surgery: delayed gastric emptying (anesthesia risk), wound healing effects, facial volume loss requiring restoration, body contouring timing, medication hold protocols. Covers all major GLP-1 drugs.
Why it matters
As millions take GLP-1 drugs, plastic surgeons increasingly encounter these patients. Understanding drug interactions with surgery is essential for patient safety and optimal cosmetic outcomes.
How the study worked
Practical narrative review for plastic surgeons covering GLP-1 drug mechanisms, surgical implications, and management recommendations.
What this study cannot tell us
Practical guidance based on limited evidence. Most recommendations are expert opinion. Surgical outcome data for GLP-1 patients is scarce.
How to read the evidence
Expert-level practical review. Limited evidence base; mostly consensus recommendations.
When this study was published
Published in 2025.
The bigger picture
The surge in GLP-1 drug use is creating new patient populations for plastic surgery—both from "Ozempic face" facial deflation and from excess skin after major weight loss. Surgeons need to adapt their practice.
Questions still open
- How long should GLP-1 drugs be held before surgery?
- Does rapid weight loss on GLP-1 drugs affect wound healing?
- Should GLP-1 drug use be incorporated into preoperative screening?
Common questions
Should I stop GLP-1 drugs before cosmetic surgery?
Does weight loss from GLP-1 drugs affect plastic surgery results?
Read the original research
Glucagon-Like Peptide-1 Agonists: A Practical Overview for Plastic and Reconstructive Surgeons.
Annals of plastic surgery, 94(1), 121-127
Citation
Stanton, Eloise W; Manasyan, Artur; Banerjee, Rakhi; Hong, Kurt; Koesters, Emma; Daar, David A. (2025). Glucagon-Like Peptide-1 Agonists: A Practical Overview for Plastic and Reconstructive Surgeons.. Annals of plastic surgery, 94(1), 121-127. https://doi.org/10.1097/SAP.0000000000004089